The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Five orthopedic implant makers, including embattled Medtronic, have received letters from the Securities and Exchange Commission indicating the SEC intends to investigate claims that the companies may have made improper payments to foreign officials. The companies who’ve received the letters are Medtronic, Zimmer, Biomet, Smith & Nephew, and Stryker. Medtronic, known for its cardiac defibrillators, is facing class action lawsuits as a result of defective leads in its Sprint Fidelis defibrillator.

For more information on this subject, please refer to the section on Drug, Medical Devices, and Implants.

Comments are closed.

Of Interest